Together, our findings highlight the importance of XCL1-XCR1 axis in anti-tumor response, indicating that immunotherapeutic effect may be enhanced by recruiting XCL1+CD8+ T cells into HCC. This evidence concerns the gene XCR1 and hepatocellular carcinoma.